Sources | Names Used |
---|---|
CTRPv2 | BRD-K04800985 |
PharmacoGx | BRD-K04800985 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEACAM19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PRF1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | SPAG11B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | HECTD1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | IL26 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | LMF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RP3-461F17.3 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | TMED4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | C3orf30 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | HNRNPA2B1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |